Diabetic eye disease Archives - Insight

Dr James Muecke: The tide is turning on diabetes

Staff Writer — Fri, 27 Sep 2024 22:31:59 +0000

Dr James Muecke (left) meeting with Federal Health Minister Mark Butler to share his diabetes prevention strategy in August 2023. Image: James Muecke.

Ophthalmologist and 2020 Australian of the Year DR JAMES MUECKE has been a prominent voice in a recent government inquiry into the state of diabetes in Australia. After completely changing his
Read More

The post Dr James Muecke: The tide is turning on diabetes appeared first on Insight.

Diabetic macular oedema ‘reversed’ in 15 Adelaide patients with diet

Myles Hume — Tue, 03 Sep 2024 21:00:12 +0000

They study retrospectively analysed OCT scans of 15 DMO patients at a private metropolitan ophthalmology practice. Image: Sergey Ryzhov/Shutterstock.com.

Ophthalmologist Dr James Muecke and South Australian colleagues have reported 15 cases of people reversing their diabetic macular oedema (DMO) using only their diet. The work – involving the Read More

The post Diabetic macular oedema ‘reversed’ in 15 Adelaide patients with diet appeared first on Insight.

The return rate of KeepSight patients

Staff Writer — Fri, 26 Jul 2024 04:36:17 +0000

OCT has been highlighted as one of the most influential pieces of technology to detect and monitor retinal changes in people with diabetes. Image: Specsavers.

Data collected by Specsavers has revealed KeepSight – Australia’s diabetes eye check reminder program – is significantly enhancing patient adherence to regular eye health appointments. Patients
Read More

The post The return rate of KeepSight patients appeared first on Insight.

Ophthalmic voice prominent in 2024 national diabetes inquiry

Myles Hume — Tue, 16 Jul 2024 06:00:48 +0000

Diabetic retinopathy is the most common diabetic eye disease, affecting between 300,000 and 400,000 Australians. Image: 777 Bond vector/Shutterstock.com.

The ophthalmic sector has weighed in on a major government inquiry into the state of diabetes in Australia, drawing attention to “pervasive and persuasive” food marketing to children and barriers to
Read More

The post Ophthalmic voice prominent in 2024 national diabetes inquiry appeared first on Insight.

AI scan for diabetes has potential to save sight and money

Staff Writer — Mon, 15 Jul 2024 05:25:58 +0000

An accurate AI-powered camera could prevent up to 40,000 cases of blindness from diabetic retinopathy. Image: Who is Danny/stock.adobe.com.

Modelling has revealed integrating an artificial intelligence (AI) powered scan for diabetic retinopathy into routine healthcare can increase detection of the disease, while also reducing costs across
Read More

The post AI scan for diabetes has potential to save sight and money appeared first on Insight.

MDFA launches Australia’s first comprehensive AMD support service

Staff Writer — Tue, 09 Jul 2024 04:41:04 +0000

The response to the MDFA's launch of the Eye Connect service has been positive. Image: MDFA.

Macular Disease Foundation Australia (MDFA) has launched Eye Connect, a comprehensive support service for people living with macular disease and described as the first of its kind in Australia. Of the
Read More

The post MDFA launches Australia’s first comprehensive AMD support service appeared first on Insight.

Ozempic may be linked to increased risk of blindness

Staff Writer — Mon, 08 Jul 2024 03:36:23 +0000

Researchers found 8.9% of patients on semaglutide had NAION compared with 1.8% on the other drugs, over a three-year period. Image: myskin/stock.adobe.com.

A new study has found patients prescribed semaglutide for diabetes or weight loss had a higher risk of developing a blinding eye condition. It was found that patients prescribed semaglutide – more commonly
Read More

The post Ozempic may be linked to increased risk of blindness appeared first on Insight.

Eylea 8mg now registered with Australian TGA

Staff Writer — Mon, 24 Jun 2024 01:45:01 +0000

EYLEA 8 mg is indicated in adults for neovascular age-related macular degeneration and diabetic macular oedema. Image: dragonstock/stock.adobe.com.

The Australian Therapeutic Goods Administration (TGA) has approved Eylea 8mg, a higher dose of aflibercept for adults with neovascular aged-related macular degeneration (nAMD) and diabetic macular oedema
Read More

The post Eylea 8mg now registered with Australian TGA appeared first on Insight.

Specsavers reaches one million KeepSight appointment registrations

Myles Hume — Sun, 09 Jun 2024 22:04:31 +0000

Each week, Specsavers optometrists in Australia refer more than 7,000 patients with detected diabetes to KeepSight. Image: Specsavers.

Specsavers optometrists nationwide have reached one million appointments registered with the KeepSight national diabetes eye check reminder program. This number includes new and returning patients with
Read More

The post Specsavers reaches one million KeepSight appointment registrations appeared first on Insight.

Cerulea Clinical Trials to boost access to sight-saving therapies

Staff Writer — Wed, 22 May 2024 00:11:32 +0000

The centre is located at the Royal Victorian Eye and Ear Hospital in East Melbourne. Image: CERA.

The Centre for Eye Research Australia (CERA) has established Cerulea Clinical Trials, a new specialist ophthalmic clinical trial facility in Melbourne which is expected to bring more international trials
Read More

The post Cerulea Clinical Trials to boost access to sight-saving therapies appeared first on Insight.